← ANALYST RATINGS · TIPRANKS
Electromed (ELMD): analyst forecast and price target
Analyst consensus
Moderate Buy1 Buy0 Hold0 Sell
Ratings of 1 analysts in the last 3 months12-month forecast
Based on 1 price targets given in the last 3 months, the average target is $47.00, the highest $47.00, the lowest $47.00. The average is +71.4% from the last price of $27.42.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $30.00 | Buy | +9.4% | Reiterated | 22.09.26on TipRanks Sep 21 23:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $29.00 | Hold | +5.8% | Reiterated | 22.09.26on TipRanks Sep 21 23:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $30.00 | Buy | +9.4% | Reiterated | 22.09.26on TipRanks Sep 21 23:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $29.00 | Buy | +5.8% | Reiterated | 22.09.26on TipRanks Sep 21 23:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $30.00 | Buy | +9.4% | Reiterated | 22.09.26on TipRanks Sep 21 23:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $30.00 | Buy | +9.4% | Reiterated | 22.09.26on TipRanks Sep 21 23:05 | — | |
| Ben Haynor★★★★★★★★★★#11216 · hits 35% · avg −2.8% | Lake Street | $36.00 → $47.00+30.6% | Buy | +71.4% | Reiterated | 26.08.26on TipRanks 09:00 | −19.3%next day −5.8% · 5 days −11.0% | ↗ |
| Anderson Schock★★★★★★★★★★#6225 · hits 53% · avg +2.9% | B. Riley Securities | $38.00 → $40.00+5.3% | Buy | +45.9% | Reiterated | 13.05.26on TipRanks 09:35 | +24.6%next day +6.5% · 5 days +11.0% | ↗ |
| Kyle Bauser★★★★★★★★★★#12304 · hits 37% · avg −14.9% | Roth MKM | $38.00 | Buy | +38.6% | Reiterated | 20.02.26on TipRanks 06:50 | −0.1%next day +1.6% · 5 days −1.8% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Electromed
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $47.00 at a price of $28.23 (+66.5%); now: $47.00 at $27.42 (+71.4%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 10.11.26 (Q1 2027, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.26 (from $0.22 to $0.29). Last quarter: $0.39.
Sales
Next quarter’s sales estimate — $19M (from $19M to $19M). Last quarter: $19M.
Best top-analyst consensus in the sector · Healthcare
About Electromed
- CEO: James L. Cunniff
- Employees: 196
- 500 Sixth Avenue NW, New Prague, MN, 56071, US
- smartvest.com
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Data from the stock’s TipRanks forecast page, read 382 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗